Please sign in to follow a disease.
New pain block may cut opioid use after knee surgery
NCT ID NCT05962970
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a continuous nerve block (a small tube that delivers numbing medicine for days) can improve pain control and reduce opioid use after knee replacement surgery. Sixty adults having same-day knee replacement were enrolled. The goal was to see if this approach leads to less pain, fewer side effects, and a better recovery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
60 people
The number who actually took part.
- Started
-
Oct 2023
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients undergoing unilateral primary TKA in the fast track setting. * Patients older than 21 years of age, with American Society of Anesthesiologists (ASA) * Physical status I-III * No alcohol or drug dependency * Sufficient understand and co-operation about the perineural catheter. Exclusion Criteria: * Perioperative complication or discharge delay leading to hospital admission. * Chronic opioid use of morphine 30mg equivalent per day for last 2 consecutive weeks. * Allergy to the study medications; * Coagulopathy and platelet count \< 105/μL; * Patients with contraindications to the insertion of an epidural or adductor canal catheter (severe anatomic abnormalities or history of previous surgery at the site of catheter placement).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Total knee arthroplasty are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mount Sinai Hospital, Toronto
Toronto, Ontario, M5G 1X5, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- What do knee replacement patients really need to know? a study asks them
- Prepping the knee before surgery: a new approach to better recovery
- Which nerve drug wins the battle against Post-Surgical knee pain?
- Can a single steroid dose transform knee replacement recovery?
- Can the right anesthesia get knee replacement patients moving faster?
- Can relaxation exercises boost recovery after knee replacement?